In a tight competition to rank the top ten innovations for 2013, The Scientist recently published its definitive list.
The Prosigna Breast Cancer Progonostic Gene Signature Assay ranked 4th and Aleix Prat, Principal Investigator of VHIO´s Translational Genomics Group, was subsequently invited to comment based on his experience working with the Nanostring assay.
